RaySearch Laboratories AB (publ)
RSLBF News Today: Stay Updated with the Latest RaySearch Laboratories AB (publ) News in Real Time
Find RSLBF news now at Meyka AI. Stay informed with the latest RaySearch Laboratories AB (publ) stocks updates, including price news, market analysis, and expert insights.
UBS Maintains Buy on Abbott Laboratories (ABT) March 13, 2026
UBS maintained Buy on Abbott; ABT analyst rating held Buy on March 13, 2026
XVIPY $6.54 Xvivo Perfusion AB (PNK) 13 Mar 2026: oversold bounce, watch $8.00 target
XVIPY stock at $6.54 shows an oversold bounce on 13 Mar 2026; Meyka AI forecast 1-year $9.58, implied upside 46.48%
DOE Launches First Distinguished Mentor Awards to Honor STEM Leaders
The DOE, the United States Department of Energy, has announced the launch of its first Distinguished Mentor Awards, a new initiative designed to recognize outstanding mentorship in science, technology, engineering, and mathematics. The program aims to celebrate leaders who have helped train the next generation of scientists and innovators across national laboratories, universities, and research…
Pre-market volume spike: 8072.T Japan Publ. Trading (JPX) 11 Mar 2026 orders
Pre-market volume spike on 8072.T stock at JPY 3980; we review flows, valuation, and Meyka AI’s forecast
ISRO Partners With AIIMS to Advance Space Medicine Research
India has taken a major step forward in human space exploration as ISRO officially partnered with the All India Institute of Medical Sciences (AIIMS) to strengthen research in space medicine. The collaboration represents a significant milestone in combining medical science with space technology, aiming to understand how space environments affect the human body and how…
GreenMerc AB (L5L.F) XETRA rises 20.65% intraday 09 Mar 2026: short-term outlook
Intraday: L5L.F stock up 20.65% at €0.33 on XETRA 09 Mar 2026. Meyka AI analysis and forecast
HMPV Surge March 9: California Wastewater Spike Puts Care Demand in Focus
HMPV surge in California wastewater raises care demand risks. What it means for Australia’s hospitals, insurers, and staffing, plus investor metrics to watch.
Intraday drop: ABT.SW stock down 12.00% on SIX as price hits CHF88.00, what analysts watch next
Intraday: ABT.SW stock falls 12.00% to CHF88.00 on SIX; quick analysis, Meyka grade and a CHF100.11 forecast
ABT.SW stock intraday: CHF88.00 falls 12.00% on SIX, analysts watch support
ABT.SW stock down **12.00%** to CHF88.00 intraday on SIX; key metrics, Meyka AI grade, and CHF100.11 12-month outlook